Patent Assignment
Reel/Frame 059436/0236
Assignment of Assignor's Interest
Recorded: 2022-03-18
Pages: 26
Assignor
BOTULINUM TOXIN RESEARCH ASSOCIATES, INC.
Executed: 2016-06-02
Assignee
REVANCE THERAPEUTICS, INC.
7555 GATEWAY BOULEVARD, NEWARK, CALIFORNIA, 94560
Covered Properties
(2)
Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
Application:
17/183,934 →
Publication:
US 2021/0283228
Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
Application:
17/234,690 →
Publication:
US 2021/0308236
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 18, 2022
From: BORODIC, GARY E.
To: BOTULINUM TOXIN RESEARCH ASSOCIATES, INC.
Reel/Frame 059440/0061 →
Security Interest
Mar 18, 2022
From: REVANCE THERAPEUTICS, INC.
To: ATHYRIUM BUFFALO LP
Reel/Frame 059437/0654 →
Release of Security Interest
Feb 7, 2025
From: ATHYRIUM BUFFALO LP
To: REVANCE THERAPEUTICS, INC
Reel/Frame 070153/0630 →
Security Interest
Feb 7, 2025
From: REVANCE THERAPEUTICS, INC.; CROWN LABORATORIES, INC.
To: HAYFIN SERVICES LLP, AS ADMINISTRATIVE AGENT
Reel/Frame 070153/0663 →
Security Interest
Feb 7, 2025
From: REVANCE THERAPEUTICS, INC.; BELLUS MEDICAL, LLC; CROWN LABORATORIES, INC.
To: HAYFIN SERVICES LLP, AS ADMINISTRATIVE AGENT
Reel/Frame 070153/0736 →
Security Interest
Feb 17, 2025
From: REVANCE THERAPEUTICS, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 070239/0739 →